This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Apr;12(4):e005530.

doi: 10.1161/CIRCOUTCOMES.119.005530.

More or Less Medication: Is One Better than the Other?

Susan K Bowles^{1

2}, Melissa K Andrew^{3

2}

Affiliations

Affiliations

¹ College of Pharmacy and Department of Medicine (Geriatrics) (S.K.B.), Dalhousie University, Halifax, NS.
² Departments of Pharmacy and Medicine (Geriatrics) (S.K.B.), Nova Scotia Health Authority, Halifax, NS.
³ Department of Medicine (Geriatrics) (M.K.A.), Dalhousie University, Halifax, NS.

PMID: 31002000
DOI: 10.1161/CIRCOUTCOMES.119.005530

Editorial

More or Less Medication: Is One Better than the Other?

Susan K Bowles et al. Circ Cardiovasc Qual Outcomes. 2019 Apr.

. 2019 Apr;12(4):e005530.

doi: 10.1161/CIRCOUTCOMES.119.005530.

Authors

Susan K Bowles^{1

2}, Melissa K Andrew^{3

2}

Affiliations

¹ College of Pharmacy and Department of Medicine (Geriatrics) (S.K.B.), Dalhousie University, Halifax, NS.
² Departments of Pharmacy and Medicine (Geriatrics) (S.K.B.), Nova Scotia Health Authority, Halifax, NS.
³ Department of Medicine (Geriatrics) (M.K.A.), Dalhousie University, Halifax, NS.

PMID: 31002000
DOI: 10.1161/CIRCOUTCOMES.119.005530

No abstract available

Keywords: Editorials; chronic disease; mortality; myocardial infarction; secondary prevention.

PubMed Disclaimer

Comment on

Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction.
Zullo AR, Mogul A, Corsi K, Shah NR, Lee SJ, Rudolph JL, Wu WC, Dapaah-Afriyie R, Berard-Collins C, Steinman MA. Zullo AR, et al. Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e004942. doi: 10.1161/CIRCOUTCOMES.118.004942. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31002274 Free PMC article.

Similar articles

Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.
Huber CA, Meyer MR, Steffel J, Blozik E, Reich O, Rosemann T. Huber CA, et al. Clin Ther. 2019 Jan;41(1):107-117. doi: 10.1016/j.clinthera.2018.11.012. Epub 2018 Dec 24. Clin Ther. 2019. PMID: 30591287
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
Evans M, Carrero JJ, Szummer K, Åkerblom A, Edfors R, Spaak J, Jacobson SH, Andell P, Lindhagen L, Jernberg T. Evans M, et al. J Am Coll Cardiol. 2016 Apr 12;67(14):1687-97. doi: 10.1016/j.jacc.2016.01.050. J Am Coll Cardiol. 2016. PMID: 27056774
Angiotensin-converting enzyme inhibitors in acute myocardial infarction: a clinical approach.
Lubarsky L, Coplan NL. Lubarsky L, et al. Prev Cardiol. 2007 Summer;10(3):156-9. doi: 10.1111/j.1520-037x.2007.06007.x. Prev Cardiol. 2007. PMID: 17617779 Review.
Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?
Pilote L, Abrahamowicz M, Rodrigues E, Eisenberg MJ, Rahme E. Pilote L, et al. Ann Intern Med. 2004 Jul 20;141(2):102-12. doi: 10.7326/0003-4819-141-2-200407200-00008. Ann Intern Med. 2004. PMID: 15262665
AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M, Lamas GA. Azadpour M, et al. Expert Rev Cardiovasc Ther. 2004 Nov;2(6):891-902. doi: 10.1586/14779072.2.6.891. Expert Rev Cardiovasc Ther. 2004. PMID: 15500434 Review.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information